Growth inhibition associated with disruption of the actin cytoskeleton by Latrunculin A in rhabdomyosarcoma cells

Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase

(2018) Dana M. Gwinn et al.   CANCER CELL

Latrunculin A Accelerates Actin Filament Depolymerization in Addition to Sequestering Actin Monomers

(2018) Ikuko Fujiwara et al.   CURRENT BIOLOGY

The cytoskeletal inhibitors latrunculin A and blebbistatin exert antitumorigenic properties in human hepatocellular carcinoma cells by interfering with intracellular HuR trafficking

(2015) Anke Doller et al.   EXPERIMENTAL CELL RESEARCH

Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcoma

(2015) Simone Hettmer et al.   eLife

Systemic treatment of soft-tissue sarcoma—gold standard and novel therapies

(2014) Mark Linch et al.   Nature Reviews Clinical Oncology

Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors

(2014) J. F. Shern et al.   Cancer Discovery

Rhabdomyosarcoma: Current Challenges and Their Implications for Developing Therapies

(2014) S. Hettmer et al.   Cold Spring Harbor Perspectives in Medicine

Classification of Rhabdomyosarcoma and Its Molecular Basis

(2013) David M. Parham et al.   ADVANCES IN ANATOMIC PATHOLOGY

What is new in the biology and treatment of pediatric rhabdomyosarcoma?

(2013) Douglas S. Hawkins et al.   CURRENT OPINION IN PEDIATRICS

Bortezomib Stabilizes Mitotic Cyclins and Prevents Cell Cycle Progression via Inhibition of UBE2C in Colorectal Carcinoma

(2011) Prashant Bavi et al.   AMERICAN JOURNAL OF PATHOLOGY

UA62784 Is a Cytotoxic Inhibitor of Microtubules, not CENP-E

(2011) Sergey Tcherniuk et al.   CHEMISTRY & BIOLOGY

Collagen Fragments Inhibit Hyaluronan Synthesis in Skin Fibroblasts in Response to Ultraviolet B (UVB)

(2011) Katharina Röck et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing program

(2011) Richard B. Lock et al.   PEDIATRIC BLOOD & CANCER

Activation of Ras Requires the ERM-Dependent Link of Actin to the Plasma Membrane

(2011) Tobias Sperka et al.   PLoS One

Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells

(2011) S. Hettmer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications

(2010) Zhi Sheng et al.   NATURE MEDICINE

Initial testing (stage 1) of the multi-targeted kinase inhibitor sorafenib by the pediatric preclinical testing program

(2010) Stephen T. Keir et al.   PEDIATRIC BLOOD & CANCER

UA62784, a novel inhibitor of centromere protein E kinesin-like protein

(2009) M. C. Henderson et al.   MOLECULAR CANCER THERAPEUTICS

Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups

(2008) Odile Oberlin et al.   JOURNAL OF CLINICAL ONCOLOGY

Latrunculin A and Its C-17-O-Carbamates Inhibit Prostate Tumor Cell Invasion and HIF-1 Activation in Breast Tumor Cells⊥

(2008) Khalid A. El Sayed et al.   JOURNAL OF NATURAL PRODUCTS

Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program

(2007) Peter J. Houghton et al.   PEDIATRIC BLOOD & CANCER